| 期 |
栏目 |
标题 |
文件 |
| 编号 18 (2012) |
Articles |
A new approach to the overcoming resistance to hormone therapy of breast cancer |
|
| 编号 8 (2013) |
Articles |
ROL' IMMUNOKON\"YuGATOV V TARGETNOY TERAPII ZLOKAChESTVENNYKh OPUKhOLEY |
|
| 编号 17 (2013) |
Articles |
Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy |
|
| 编号 8 (2016) |
Articles |
NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER |
|
| 编号 17 (2016) |
Articles |
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER" |
|
| 编号 17 (2016) |
Articles |
TAXANES IN THE TREATMENT OF BREAST CANCER |
|
| 编号 17 (2017) |
Articles |
De-escalation and escalation of treatment of patients with HER2-positive breast cancer |
|
| 编号 17 (2017) |
Articles |
New possibilities of the treatment of breast cancer: microtubule inhibitors |
|
| 编号 6 (2018) |
Articles |
EXPERIENCE OF USE OF NEOADJUVANT DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN AND CISPLATIN IN COMBINED TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER: PROSPECTIVE SINGLE-CENTER NON-RANDOMIZED CONTROLLED STUDY |
|
| 编号 7 (2018) |
Articles |
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER |
|
| 编号 7 (2018) |
Articles |
TREATMENT OF RELAPSES AND RESISTANT FORMS OF HODGKIN'S LYMPHOMA |
|
| 编号 12 (2018) |
Articles |
Potentials of drug therapy for metastatic/recurrent cervical cancer |
|
| 编号 12 (2018) |
Articles |
Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities |
|
| 卷 26, 编号 7 (2019) |
Articles |
The role of the medical psychologist in the multidisciplinary team for the rehabilitation of cancer patients |
|
| 卷 26, 编号 12 (2019) |
Articles |
The predictive value of nutritional deficiency in the treatment of patients with locally advanced stomach cancer |
|
| 卷 27, 编号 7 (2020) |
Articles |
Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study |
|
| 卷 27, 编号 7 (2020) |
Articles |
Prospects for the use of immunotherapy in the treatment of head and neck squamous cell carcinoma |
|
| 卷 27, 编号 7 (2020) |
Articles |
Antivital experiences of oncologic patients against the background of antitumor treatment and in the long term period |
|
| 卷 27, 编号 7 (2020) |
Articles |
Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors |
|
| 卷 27, 编号 11 (2020) |
Articles |
Neoadjuvant and postneoadjuvant treatment for triple negative breast cancer |
|
| 卷 28, 编号 7 (2021) |
Articles |
Consolidation of high-dose chemotherapy with transplantation of autologous hematopoietic stem cells of the first remission of diffuse large B-cell lymphoma |
|
| 卷 28, 编号 7 (2021) |
Articles |
Impact of nutritional deficiency and sarcopenia on the efficacy of neoadjuvant chemotherapy in patients with locally advanced gastric cancer: a retrospective study |
|
| 卷 28, 编号 7 (2021) |
Articles |
Features of examination and systemic treatment of malignant neoplasms in gerontological patients |
|
| 卷 29, 编号 7 (2022) |
Articles |
Modern aspects of nutritional support during hematopoietic stem cell transplantation: review, experience of the N.N. Petrov National Medical Research Center of Oncology |
|
| 卷 29, 编号 7 (2022) |
Articles |
Approaches to the mobilization of hematopoietic stem cells: a literature review |
|
| 卷 29, 编号 11/12 (2022) |
Articles |
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer |
|
| 卷 29, 编号 11/12 (2022) |
Articles |
Ixabepilone in the treatment of breast cancer |
|
